Volume 6, Issue 11, Pages (November 1998)

Slides:



Advertisements
Similar presentations
Elena Conti, Nick P Franks, Peter Brick  Structure 
Advertisements

Volume 10, Issue 8, Pages (August 2002)
Volume 6, Issue 1, Pages (January 1998)
Structure-based design of peptide presentation on a viral surface: the crystal structure of a plant/animal virus chimera at 2.8 å resolution  Tianwei.
Crystal Structure of the Tandem Phosphatase Domains of RPTP LAR
Crystal structure of the chemotaxis receptor methyltransferase CheR suggests a conserved structural motif for binding S-adenosylmethionine  Snezana Djordjevic,
Volume 10, Issue 8, Pages (August 2002)
Conformational Changes of the Flavivirus E Glycoprotein
Kristopher Josephson, Naomi J. Logsdon, Mark R. Walter  Immunity 
Volume 6, Issue 2, Pages (February 1998)
Volume 124, Issue 1, Pages (January 2006)
Volume 25, Issue 11, Pages e2 (November 2017)
Atomic Model of CPV Reveals the Mechanism Used by This Single-Shelled Virus to Economically Carry Out Functions Conserved in Multishelled Reoviruses 
Volume 7, Issue 12, Pages (January 1999)
Volume 15, Issue 4, Pages (April 2007)
Volume 124, Issue 2, Pages (January 2006)
Volume 23, Issue 1, Pages (July 2006)
Crystal structure of human mitochondrial NAD(P)+-dependent malic enzyme: a new class of oxidative decarboxylases  Yingwu Xu, Girija Bhargava, Hao Wu,
Tom Huxford, De-Bin Huang, Shiva Malek, Gourisankar Ghosh  Cell 
Crystal Structure of the Soluble Form of Equinatoxin II, a Pore-Forming Toxin from the Sea Anemone Actinia equina  Alekos Athanasiadis, Gregor Anderluh,
Structure of RGS4 Bound to AlF4−-Activated Giα1: Stabilization of the Transition State for GTP Hydrolysis  John J.G. Tesmer, David M. Berman, Alfred G.
Human rhinovirus 3 at 3.0 å resolution
Volume 23, Issue 7, Pages (July 2015)
Volume 3, Issue 11, Pages (November 1995)
Volume 5, Issue 3, Pages (March 1997)
Volume 26, Issue 2, Pages e3 (February 2018)
DNA packaging intermediates of bacteriophage φX174
Volume 6, Issue 12, Pages (December 1998)
Crystal Structures of Ral-GppNHp and Ral-GDP Reveal Two Binding Sites that Are Also Present in Ras and Rap  Nathan I. Nicely, Justin Kosak, Vesna de Serrano,
Crystal Structures of a Novel Ferric Reductase from the Hyperthermophilic Archaeon Archaeoglobus fulgidus and Its Complex with NADP+  Hsiu-Ju Chiu, Eric.
Volume 18, Issue 6, Pages (June 2010)
Structure of mammalian ornithine decarboxylase at 1
N Khazanovich, KS Bateman, M Chernaia, M Michalak, MNG James  Structure 
Volume 4, Issue 5, Pages (November 1999)
Volume 124, Issue 5, Pages (March 2006)
Andrew H. Huber, W.James Nelson, William I. Weis  Cell 
Volume 9, Issue 8, Pages (August 2001)
Volume 16, Issue 10, Pages (October 2008)
Volume 9, Issue 12, Pages (December 2001)
The structure of coxsackievirus B3 at 3.5 å resolution
Noncatalytic Assembly of Ribonuclease III with Double-Stranded RNA
Volume 6, Issue 11, Pages (November 1998)
Edith Schlagenhauf, Robert Etges, Peter Metcalf  Structure 
Volume 91, Issue 5, Pages (November 1997)
Volume 6, Issue 6, Pages (December 2000)
The structure of an RNA dodecamer shows how tandem U–U base pairs increase the range of stable RNA structures and the diversity of recognition sites 
Volume 8, Issue 11, Pages (November 2000)
Volume 6, Issue 2, Pages (February 1998)
Volume 2, Issue 5, Pages (May 1994)
Volume 9, Issue 12, Pages (December 2001)
Volume 8, Issue 10, Pages (October 2000)
Elena Conti, Nick P Franks, Peter Brick  Structure 
Volume 2, Issue 4, Pages (April 1994)
The crystal structure of bacteriophage Qβ at 3.5 å resolution
Volume 6, Issue 1, Pages (January 1998)
Tertiary Structure of Destrin and Structural Similarity between Two Actin-Regulating Protein Families  H Hatanaka, K Ogura, K Moriyama, S Ichikawa, I.
Volume 34, Issue 3, Pages (May 2009)
Crystal Structure of the Human Myeloid Cell Activating Receptor TREM-1
Structure of the Staphylococcus aureus AgrA LytTR Domain Bound to DNA Reveals a Beta Fold with an Unusual Mode of Binding  David J. Sidote, Christopher.
Crystal structure of the apoptotic suppressor CrmA in its cleaved form
Structure of a water soluble fragment of the ‘Rieske’ iron–sulfur protein of the bovine heart mitochondrial cytochrome bc1 complex determined by MAD phasing.
Volume 2, Issue 7, Pages (July 1994)
Hideki Kusunoki, Ruby I MacDonald, Alfonso Mondragón  Structure 
The 2.0 å structure of a cross-linked complex between snowdrop lectin and a branched mannopentaose: evidence for two unique binding modes  Christine Schubert.
Human glucose-6-phosphate dehydrogenase: the crystal structure reveals a structural NADP+ molecule and provides insights into enzyme deficiency  Shannon.
Stacy D Benson, Jaana K.H Bamford, Dennis H Bamford, Roger M Burnett 
Volume 8, Issue 5, Pages (May 2000)
Kristopher Josephson, Naomi J. Logsdon, Mark R. Walter  Immunity 
The Structure of T. aquaticus DNA Polymerase III Is Distinct from Eukaryotic Replicative DNA Polymerases  Scott Bailey, Richard A. Wing, Thomas A. Steitz 
Volume 8, Issue 11, Pages (November 2000)
Presentation transcript:

Volume 6, Issue 11, Pages 1369-1381 (November 1998) Functional implications of the structure of the murine parvovirus, minute virus of mice  Mavis Agbandje-McKenna, Antonio L Llamas-Saiz, Feng Wang, Peter Tattersall, Michael G Rossmann  Structure  Volume 6, Issue 11, Pages 1369-1381 (November 1998) DOI: 10.1016/S0969-2126(98)00137-3

Figure 1 The amino acid sequence of MVMi. The alignment was made on the basis of a structural superposition of the VP2 capsid protein of CPV with that of MVMi. Secondary structure elements are labeled; residues that are conserved between CPV and MVMi are in bold and residues that differ between MVMi and MVMp are underlined. Regions of the amino acid sequence with insertions (in 1 – 6, cyan) and deletions (dl 1 – 7, magenta) in MVMi relative to CPV are indicated. The two allotropic residues of MVMi, 317 and 321, are shown in red. Less ordered regions in the MVMi electron-density map are shown boxed. The arrow indicates the first modeled residue. Structure 1998 6, 1369-1381DOI: (10.1016/S0969-2126(98)00137-3)

Figure 2 The MVMi VP2 capsid protein. (a) The topology of VP2 showing the location of the strands making up the eight-stranded β barrel (green), the fivefold β ribbon and the location of the four major surface loops 1 to 4. The N-terminal glycine-rich sequence located within the fivefold channel is shown in red; the rest of the molecule is in blue. Some amino acid sequence numbers are also shown. (b) The location of one VP2 subunit within a geometrically defined asymmetric unit viewed down an icosahedral twofold axis. The fivefold axis is represented as a black pentagon, the threefold axes as triangles and the twofold axis as an oval. The color scheme is the same as in (a). (c) A two-dimensional ‘roadmap’ of MVMi, showing the contribution of VP2 subunits in one icosahedral asymmetric unit. Dark blue represents the reference subunit as shown in (b). Yellow represents a subunit related by a twofold rotation about the axis shown in the center of the base of the triangle. Green represents a subunit related by a threefold rotation about the threefold axis at the bottom right of the triangle. Cyan represents a subunit related by a rotation about the fivefold axis at the top of the triangle. The projection is down a twofold axis. (Figures (a) and (b) were drawn with the program MOLSCRIPT [57], (c) was drawn with the program roadmap [58].) Structure 1998 6, 1369-1381DOI: (10.1016/S0969-2126(98)00137-3)

Figure 3 The MVMi capsid. Depth-cued representation of a whole MVMi particle. The particle surface shading is based on distance from the viral center: the lighter regions represent residues that are at the greatest radial distance and the darkest regions represent residues at the shortest radial distance. The icosahedral fivefold, threefold and twofold axes for one viral asymmetric unit are indicated. Structure 1998 6, 1369-1381DOI: (10.1016/S0969-2126(98)00137-3)

Figure 4 Stereoviews illustrating the mainchain differences between MVMi (blue) and CPV (red). (a) Differences in the residues lining the fivefold channel. (b) The six-residue insertion (MVM residues 554–559). (c) Differences in the ‘allotropic’ region (MVM residues 315–326 are shown). (d) The antigenic region near CPV residue 300, where there is a three-residue deletion in MVMi relative to CPV. The orientation and position of the subunits are represented by a minidiagram showing the icosahedral asymmetric unit in the same orientation. The orientation of (c) and (d) is looking down the twofold axis. (Figures were generated using the program MaclnPlot [59].) Structure 1998 6, 1369-1381DOI: (10.1016/S0969-2126(98)00137-3)

Figure 5 Stereoviews of the fivefold channel with modeled N-terminal peptides. The glycine-rich sequence in MVMi is shown in ball-and-stick representation, colored according to atom type; CPV is shown in red stick representation. The surrounding fivefold channel for MVMi is in blue and green corresponding to two fivefold-related subunits. (a) Externalization of the N-terminal extension towards the top of the figure. (b) Internalization of the N-terminal extension. (The figure was drawn with the program MaclnPlot [59].) Structure 1998 6, 1369-1381DOI: (10.1016/S0969-2126(98)00137-3)

Figure 6 Roadmap of MVMi showing capsid surface residue functions. The residues are color coded: red outline, residues in the hemagglutination loop; purple, residues in the hemagglutination loop that differ between MVMi and MVMp; gray, residues in the hemagglutination loop that are the same in MVMi and MVMp; red, MVM residues that participate in the determination of tissue tropism; yellow, MVM forward mutations (see text and Table 2 for details); blue, residues that are different in MVMi and MVMp, but do not participate in tissue tropism; green, CPV residues that determine host range (shown are MVM equivalent residues); green outline, position of MVMi residue 95 (equivalent to CPV residue 93) in the reference subunit shown in Figure 2. Some of the residues near the twofold axis are also shown in their symmetry-related positions. (The figure was drawn with the program roadmap [58].) Structure 1998 6, 1369-1381DOI: (10.1016/S0969-2126(98)00137-3)

Figure 7 Stereoviews showing interactions of the allotropic residues 317 and 321. The residues as observed in (a) the MVMi capsid and (b) modeled for the MVMp capsid. Atoms are colored according to type: carbon, yellow; nitrogen, blue; and oxygen, red. The orientation and position are shown with respect to the icosahedral triangle. (c) The chain of interactions that are disrupted in selected forward fibrotropic mutations (see Table 4). (The figures were drawn with the program MaclnPlot [59].) Structure 1998 6, 1369-1381DOI: (10.1016/S0969-2126(98)00137-3)

Figure 8 Stereoview showing the ordered ssDNA density within the MVMi virion. The red structure is common to MVMi and CPV. The blue structure is present in MVMi and may also be present, albeit not as well ordered, in CPV. The position and orientation of the structure within the icosahedral asymmetric unit is also shown. (The figure was drawn with the program MaclnPlot [59].) Structure 1998 6, 1369-1381DOI: (10.1016/S0969-2126(98)00137-3)